CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Thursday reported third-quarter net income of $2.53 billion.
On a per-share basis, the Cambridge, Britain-based company said it had net income of 81 cents. Earnings, adjusted for amortization costs and non-recurring costs, came to $1.19 per share.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share.
The pharmaceutical posted revenue of $15.19 billion in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $14.87 billion.
Astrazeneca shares have increased 24% since the beginning of the year. The stock has climbed 22% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AZN at https://www.zacks.com/ap/AZN
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
